Alain van Gool

Professor Personalized Healthcare

Radboud Universiteit Nijmegen

Netherlands

Research Interests

Explore related searches

Professors in Netherlands Professors in Immunology Immunology professors in Netherlands

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Alain van Gool is a Professor of Personalized Healthcare at Radboud Universiteit Nijmegen in the Netherlands. His research focuses on areas such as mass spectrometry applications in multiple myeloma, metabolomics for inborn errors of metabolism, and biomarker development for various diseases, including diabetes and COVID-19. He has contributed to significant studies exploring therapeutic responses and the immune response in health and disease.

Articles (11)

Year:

2025

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Assistant Professor

Radboud University Medical Center

NETHERLANDS

View details

Ron Wevers

Professor emeritus

Radboud University Medical Center

NETHERLANDS

View details

Tom Nijenhuis

Internist-nephrologist, Professor of Rare Kidney Disorders

Radboud University Medical Center

NETHERLANDS

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Alain van Gool

Research Interests

Explore related searches

Contact this professor

About

Articles (11)

Monitoring M-Protein, Therapeutic Antibodies, and Polyclonal Antibodies in a Multiparametric Mass Spectrometry Assay Provides Insight into Therapy Response Kinetics in Patients with Multiple Myeloma

The GlycoPaSER Prototype as a Real-Time N-Glycopeptide Identification Tool Based on the PaSER Parallel Computing Platform

Primary Focal Segmental Glomerulosclerosis Plasmas Increase Lipid Droplet Formation and Perilipin-2 Expression in Human Podocytes

Fasting Proinsulin Independently Predicts Incident Type 2 Diabetes in the General Population

Multiple Myeloma Minimal Residual Disease Detection: Targeted Mass Spectrometry in Blood vs Next-Generation Sequencing in Bone Marrow.

Semi-Quantitative Multiplex Profiling of the Complement System Identifies Associations of Complement Proteins with Genetic Variants and Metabolites in Age-Related Macular Degeneration.

Metabolomics-Based Screening of Inborn Errors of Metabolism: Enhancing Clinical Application with a Robust Computational Pipeline.

Clonotypic Features of Rearranged Immunoglobulin Genes Yield Personalized Biomarkers for Minimal Residual Disease Monitoring in Multiple Myeloma.

Biomarker Research and Development for Coronavirus Disease 2019 (COVID-19): European Medical Research Infrastructures Call for Global Coordination.

Understanding the increased risk of infections in diabetes: innate and adaptive immune responses in type 1 diabetes.

Common Variants Associated With <i>OSMR</i> Expression Contribute to Carotid Plaque Vulnerability, but Not to Cardiovascular Disease in Humans.

Collaborators (9)

Anneke I. den Hollander

Martijn van Duijn

Jolein Gloerich

H B P M Henry Dijkman

Blanca Scheijen

Joannes F. M. Jacobs

Guido van Mierlo

Ron Wevers

Tom Nijenhuis

Make your next move.